A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction

Clinical trial NCT05602493 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05602493
Sponsor: Xeolas Pharmaceuticals Limited
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bone Loss, Alveolar

Start date: 2022-11-22
Primary completion: 2024-10-20
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.